Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
Frequently asked questions
What sector does Apex Biotechnology Corp (1733) operate in?
Apex Biotechnology Corp belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Apex Biotechnology Corp (1733) current stock price?
As of the latest data, Apex Biotechnology Corp stock price is NT$30.30, with a previous close of NT$30.30.
What is Apex Biotechnology Corp (1733) current market capitalization?
Apex Biotechnology Corp market cap is approximately 3.03 billion.
What is Apex Biotechnology Corp (1733) Earnings Per Share (EPS)?
The trailing EPS is NT$1.90, and the forward EPS is NT$7.39.
What is Apex Biotechnology Corp (1733) Price-to-Earnings (P/E) ratio?
Apex Biotechnology Corp current P/E ratio is 15.95, with a forward P/E of 4.1.
What is Apex Biotechnology Corp (1733) EBITDA?
Apex Biotechnology Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 58.86 million.
Does Apex Biotechnology Corp (1733) pay dividends?
No. Apex Biotechnology Corp does not pay a dividend.
What is Apex Biotechnology Corp (1733) beta (volatility) score?
Apex Biotechnology Corp has a beta of 0.255, indicating lower volatility than the overall market.
